SURVYR

SNDA

Sonida Senior Living, Inc.
$32.80
−$0.74 (2.21%)Oct 27 close
Healthcare CompareTechnicals
1M3M6M1Y2Y
-7%+12%+31%+51%+70%Oct 2025Oct 2026Apr 202652w high $44.3952w low $24.95
SNDASPY
Wall St. Highest PT $65.00 (+98.2%) Wall St. Avg PT $49.50 (+50.9%)
$26$37$49$60$72POC $32Hi $65Avg $50
Underwater Drawdown %Max DD -23.8%Current -23.8%
0.0%-23.8%
Relative Strength vs SPY+11.9% vs SPYOutperforming
+64%0%-64%
1W
−$1.57 (4.57%)
1M
−$4.91 (13.02%)
3M
−$10.27 (23.84%)
6M
−$5.00 (13.23%)
YTD
+$0.19 (0.58%)
1Y
+$6.65 (25.43%)

Chart

Loading live chart…

Ratings & dials

1m · 5m · 15m · 1h · 4h · 1D

Analyst & Morningstar ratings

Consensus · Targets · Morningstar
Analyst price targets
Current price$32.80
Average target$49.50
+$16.70 (+50.9%) upsideaverage target vs current price
CurrentAverageMedian
Low$43.00
Median$49.50
High$65.00
12-month Wall Street target range
Recent analyst rating changes · 20
Upgrade
2026-09-04 · Baird upgraded SNDA from Neutral to Outperform
Reiterated
2026-09-01 · Morgan Stanley reiterated Equal-Weight on SNDA
Reiterated
2026-08-11 · Cantor Fitzgerald reiterated Overweight on SNDA
Initiated
2026-08-11 · Compass Point started covering SNDA at Buy
Initiated
2026-07-27 · Citizens started covering SNDA at Market Outperform
Reiterated
2026-06-29 · RBC Capital reiterated Outperform on SNDA
All analyst rating changes ›

Third-party ratings, not SURVYR.'s views.

Key stats & company

Market value$1.6B
P/E (next 12 months, estimated)-20.5
52-week range$24.95 – $44.39
Revenue growth (latest quarter vs a year ago)+137.1%
Dividend yieldNo dividend
Average analyst price target$49.50 (+51%)

What they do

Sonida Senior Living, Inc. owns and operates senior housing communities in the United States. The company provides independent living services, which include daily meals, transportation, social and recreational activities, laundry, housekeeping. It offers assisted living services consist of personal care services, such as assistance with activities of daily living, including ambulation, bathing, dressing.

Healthcare · Medical Care Facilities
Valuation and fundamentals

Valuation & fundamentals

Loading the valuation from SEC filings…

For information only · Important disclosures

Grades vs sector

No sector grades for SNDA yet. Grades rank S&P 1500 stocks within their sector and refresh after each daily data run, so a stock outside that index or newly covered has none.

Systematic Models

Not held by any of our 7 live models right now.

Quality Growth
Outside this model's universe or screens
 Momentum Top 15
Outside this model's universe or screens
 Momentum Blend
Not in the current book
 New Highs Growth
Outside this model's universe or screens
 SURVYR. Barbell Momentum & T-Bill Shield
Outside this model's universe or screens
 SURVYR. Physical AI Grid & Power
Outside this model's universe or screens
 SURVYR. Long Book
Not in the current book

Earnings & events

SNDA earningsNext report in 9 days
Next report · quarter Sep 2026
Thu Nov 5, 2026Before the open
EPS consensus-$0.51 range -$0.59–-$0.42
Revenue consensus$210.1M 3 analysts
Last 4 quarters · EPS vs estimate
Aug 10, 2026-$0.52est -$0.48−8.3%Below estimates
May 11, 2026-$2.39est -$1.46−63.1%Below estimates
Mar 11, 2026-$1.72est -$1.30−32.3%Below estimates
Mar 27, 2024-$2.17est -$2.12−2.5%Below estimates

In line = within 1% of the estimate.

Source: Yahoo Finance · report time: Nasdaq earnings calendar · refreshed 2026-10-24 11:23:10 ET
22-1123-0323-0523-0824-0326-0326-0526-08-2.792.76
EstimateActual (beat)Actual (miss)

Quarterly revenue

QuarterRevenueYoY
2026-06-30$207.6M+122.0%
2026-03-31$122.6M–
2025-12-31$97.7M–
2025-09-30$98.0M–
2025-06-30$93.5M–

News & catalysts

More news
Sonida Senior Living Announces Third Quarter Earnings Release Date and Conference Call
Business Wire · Oct 22
Celcuity (CELC) Is Down 17.3% After REVTORPYK US Launch And sNDA Filing News Event
Simply Wall St. · Oct 07
60 Degrees Pharmaceuticals Sets January 2027 Babesiosis Data Readout and Plans FDA Pre-sNDA Meeting
InvestorsHub · Oct 06
60 Degrees Pharmaceuticals Plans January 2027 Hospitalized Babesiosis Data Readout; Will Seek Pre-sNDA Meeting with FDA
GlobeNewswire · Oct 06
U.S. FDA Accepts sNDA and Grants Priority Review to Bayer’s Lynkuet® (elinzanetant) for a New Indication for the Treatment of Moderate to Severe Vasomotor Symptoms Due to Endocrine Therapy Related to Breast Cancer
Business Wire · Sep 28
Rating changes
Upgrade
2026-09-04 · Baird upgraded SNDA from Neutral to Outperform
Reiterated
2026-09-01 · Morgan Stanley reiterated Equal-Weight on SNDA
Reiterated
2026-08-11 · Cantor Fitzgerald reiterated Overweight on SNDA
Initiated
2026-08-11 · Compass Point started covering SNDA at Buy
Initiated
2026-07-27 · Citizens started covering SNDA at Market Outperform
Reiterated
2026-06-29 · RBC Capital reiterated Outperform on SNDA

Third-party analyst actions, not SURVYR.'s views. All rating changes

Insider trades
Simanovsky Michael
Director, 10% owner · 2026-09-01
Sell
$3.7M
Simanovsky Michael
Director, 10% owner · 2026-08-28
Sell
$181.1K
Simanovsky Michael
Director, 10% owner · 2026-08-28
Sell
$831.6K
Simanovsky Michael
Director, 10% owner · 2026-08-27
Sell
$585.0K
Simanovsky Michael
Director, 10% owner · 2026-08-26
Sell
$617.6K
Simanovsky Michael
Director, 10% owner · 2026-08-25
Sell
$4.7M
Harris Benjamin P
Director · 2026-08-14
Sell
$127.1K
Harris Benjamin P
Director · 2026-08-14
Sell
$122.3K
None
None · None
Sell
–
None
None · None
Sell
–
None
None · None
Sell
–

Stats refreshed 2026-10-24 11:23:10 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now

Morning Brief (8 AM ET) & Market Close (4:30 PM ET), weekdays

Indexes, sectors, biggest movers, rates, top news, SURVYR. model changes and what's ahead. Free, two short emails each weekday.

Editions

Free. Not investment advice. Unsubscribe anytime.

SURVYR

Free to use. No card, no ads, no auto-renew.

Systematic research · Not investment advice · Hypothetical unless marked Live · Data: Yahoo Finance (15-min delayed), SEC EDGAR, House Clerk · Important disclosures · Contact desk@coteau.app

How it worksOur promiseTermsPrivacyData statusSend feedback
Coteau 0.9 · Oct 21, 2026